Insights from 2023 ESMO Annual Meeting

 

Insights from 2023 ESMO Annual Meeting
L

ESMO 2023 Insights: "LITESPARK-005 Study - Belzutifan vs. Everolimus in Participants With Previously Treated Advanced ccRCC"

By Insights from 2023 ESMO Annual Meeting FEATURING Laurence Albiges
By Insights from 2023 ESMO Annual Meeting FEATURING Laurence Albiges
133 views
October 25, 2023
0 Comments
Login to view comments. Click here to Login
Genitourinary
09:09
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "PSMA PET-Directed Outcomes in mHSPC: Impli…

Feat. H. Abdel-Aty
03:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Pati…

Feat. E. Yekedüz
08:30
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Association of Health-Related Quality of L…

Feat. M. Morris
05:58
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Test…

Feat. A. Meuleman
05:29
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abir…

Feat. D. George
03:52
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "ARASENS Trial - PSA Outcomes With Daroluta…

Feat. F. Saad
31:30
Insights from 2023 ESMO Annual Meeting

ESMO23 Highlights in Urothelial Carcinoma

Feat. G. Sonpavde, B. McGregor
08:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Minera…

Feat. A. Dalla Volta
08:56
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment…

Feat. M. Voss
08:26
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Efficacy & Safety Outcomes With Pembro…

Feat. V. Koshkin
11:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Bladder Preservation Strategies - A Surgeo…

Feat. J. Boormans
04:48
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide …

Feat. U. De Giorgi
14:06
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The DAD Trial - SG+EV as ≥ 2L Therapy for …

Feat. B. McGregor
09:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of …

Feat. G. de Velasco
10:48
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "[177 Lu]Lu-PSMA-617 in Taxane-Naïve Patien…

Feat. O. Sartor
13:49
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "THOR Study - Erdafitinib vs. Pembrolizumab…

Feat. A. Siefker-Radtke
06:25
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The Tide-A Study - Avelumab + Intermittent…

Feat. R. Iacovelli
06:22
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "CABASTY Trial - Pain Response and HRQL Ana…

Feat. S. Oudard
05:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EV-302/KEYNOTE-A39 Study of Enfortumab Ved…

Feat. T. Powles
22:19
Insights from 2023 ESMO Annual Meeting

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Feat. G. Sonpavde
03:49
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Effect of Rapid Ultra-Low Prostate-Specifi…

Feat. A. Merseburger
06:52
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Androgen Receptor Pathway Inhibitors or Ta…

Feat. H. Grönberg
04:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Post Hoc Analysis of the CLEAR Trial - Tum…

Feat. V. Grünwald
10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland
07:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "LITESPARK-005 Study - Belzutifan vs. Evero…

Feat. L. Albiges